October 17, 2018
The Ministry of Health, Labor and Welfare (MHLW) has removed contraindications carried by statins and fibrates for their combined use in patients with reduced renal functions, with label changes affecting drugs including Lipitor (atorvastatin), Crestor (rosuvastatin), and Parmodia (pemafibrate). The...read more